Glycoproteins gI and gE of feline herpesvirus-1 are virulence genes: Safety and efficacy of a gI-gE- deletion mutant in the natural host

Virology

Volumn 220, Issue 2, 1996, Pages 299-308

  Kruger, John M ^a   Sussman, Michael D ^b   Maes, Roger K ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS VACCINE; GLYCOPROTEIN; LIVE VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; FEMALE; HERPES VIRUS; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; SAFETY; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS VIRULENCE; ANIMAL; ANIMAL DISEASE; CAT DISEASE; GENE DELETION; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; PATHOGENICITY; SERODIAGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TRACHEITIS; VIROLOGY; VIRULENCE; VIRUS SHEDDING;

ALPHAHERPESVIRINAE; ANIMALIA; FELIDAE; FELINE HERPESVIRUS 1; FELIS CATUS; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

ADMINISTRATION, INHALATION; ALPHAHERPESVIRINAE; ANIMALS; ANTIBODIES, VIRAL; CAT DISEASES; CATS; FEMALE; GENE DELETION; GLYCOPROTEINS; HERPESVIRIDAE INFECTIONS; INJECTIONS, SUBCUTANEOUS; MALE; NEUTRALIZATION TESTS; TRACHEITIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS SHEDDING;

EID: 0029665625     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0318     Document Type: Article

References (65)

1. Audonnet, J. C., Winslow, J., Allen, G., and Paolleti, E. (1990). Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. J. Gen. Virol. 71, 2969-2978.
2. Balan, P., Davis-Poynter, N., Bell, S., Atkinson, H., Browne, H., and Minson, T. (1994). An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI, or the putative gJ. J. Gen. Virol. 75, 1245-1258.
3. Banks, T. B., and Rouse, B. T. (1991). Herpesviruses-immune escape artists? Clin. Infect. Dis. 14, 933-941.
4. Bistner, S. I., Carlson, J H., Shively, J. N., and Scott, F. W. (1971). Ocular manifestations of feline herpesvirus infection. J. Am. Vet. Med. Assoc. 159, 1223-1237.
5. Brownlee, K. A. (1965). "Statistical Theory and Methodology in Science and Engineering." Wiley, New York.
6. 1, 34.5, a nonessential gene for growth in cell culture. Science 252, 1262-1266.
7. Cocker, F. M., Gaskell, R. M., Newby, T. J., Gaskel, C. J., Stokes, C. R., and Bourne, F. J. (1983). Efficacy of early (48 and 96 hour) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant. Br. Med. J. 287, 1239-1240.
8. Cocker, F. M., Newby, T. J., Gaskell, R. M., Evans, P. A., Gaskell, C. J., Stokes, C. R., Harbour, D. A., and Bourne, J. F. (1986). Response of cats to nasal vaccination with a live, modified feline herpesvirus type 1. Res. Vet. Sci. 41, 323-330.
9. Crandell, R. A. (1971). Virologic and immunologic aspects of feline rhinotracheitis virus. J. Am. Vet. Med. Assoc. 158, 922-926.
10. Crandell, R. A., and Maurer, F. D. (1958). Isolation of a feline virus associated with intranuclear inclusion bodies. Proc. Soc. Exp. Biol. Med. 97, 487-490.
11. Crandell, R. A., Rehkemper, J. A., Niemann, W. H., Ganaway, J. R., and Maurer, F. D. (1961). Experimental feline viral rhinotracheitis. J. Am. Vet. Med. Assoc. 138, 191-196.
12. Dingwell, K. S., Brunetti, C. R., Hendricks, R. L., Tang, Q., Tang, M., Rainbow, A. J., and Johnson, D. (1994). Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68, 834-845.
13. Dingwell, K. S., Doering, L. C., and Johnson, D. C. (1995). Glycoproteins E and I facilitate neuron to neuron spread of herpes simplex virus. J. Virol. 69, 7087-7098.
14. Ellis, R. (1995). Varicella vaccine. Vaccine 13, 1387-1388.
15. Ellis, T. M. (1981). Feline respiratory virus carriers in clinically healthy cats. Aust. Vet. J. 57, 115-118.
16. Enquist, L. W. (1994). Infection of the mammalian nervous system by pseudorabies virus (PRV). Semin. Virol. 5, 221-231.
17. Enquist, L. W., Dubin, J., Whealy, M. E., and Card, J. P. (1994). Complementation analysis of pseudorabies virus gE and gI mutants in retinal ganglion cell neurotropism. J. Virol. 68, 5275-5279.
18. Evermann, J. F., Mckeirnan, A. J., Ott, R. L., and Reed, L. A. (1982). Diarrheal condition in dogs associated with viruses antigenically related to feline herpesvirus. Cornell Vet. 72, 285-291.
19. Fawl, R. L., and Roizman, B. (1994). The molecular basis of herpes simplex pathogenicity. Semin. Virol. 5, 261-271.
20. Fitzpatrick, D. R., and Bielefeldt-Ohmann, H. (1991). Mechanism of herpesvirus immunoevasion. Microb. Pathog. 10, 253-259.
21. Fruh, K., Kwangseog, A., Djaballah, H., Sempe, P., van Endert, P., and Yang, Y. (1995). A viral inhibitor of peptide transporter for antigen presentation. Nature 375, 415-418.
22. Gaskell, R. M. (1993). Upper respiratory disease in the cat (including chlamydia): Control and prevention. Feline Pract. 21, 29-34.
23. Gaskell, R. M., and Povey, R. C. (1979a). The dose response of cats to experimental infection with feline viral rhinotracheitis virus. J. Comp. Pathol. 89, 179-191.
24. Gaskell, R. M., and Povey, R. C. (1979b). Feline viral rhinotracheitis: Sites of virus replication and persistence in acutely and persistently infected cats. Res. Vet. Sci. 27, 167-174.
25. Gaskell, R. M., and Povey, R. C. (1982). Transmission of feline rhinotracheitis. Vet. Rec. 111, 359-362.
26. Hickman, M. A., Reubel, G. H., Hoffman, D. E., Morris, J. G., Rogers, Q. R., and Pedersen, N. C. (1993). An epizootic of feline herpesvirus, type 1 in a large specific pathogen-free cat colony and attempts to eradicate the infection by identification and culling of carriers. Lab. Anim. 28, 320-329.
27. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
28. Irie, H., Harada, Y., Kataoka, M., Nagamuta, M., Moriya, Y., Handa, M., Saito, M., Matsubara, S., Kojima, K., and Sugawara, Y. (1992). Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine. J. Virol. 66, 2428-2434.
29. Irie, H., Shimeld, C., Williams, N., and Hill, T. (1993). Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunization with live virus. J. Gen. Virol. 74, 1357-1362.
30. Israel, B. A., Herber, R., Gao, Y., and Letchworth, G. (1992). Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. Virology 188, 256-264.
31. Jacobs, L. (1994). Glycoprotein E of pseudorabies virus and homologous proteins in other herpesviruses. Arch. Virol. 137, 209-228.
32. Jacobs, L., Mulder, W. A. M., Van Oirschot, J. T., Gielkens, A. L. J., and Kimman, T. G. (1993). Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity. J. Gen. Virol. 74, 2201-2206.
33. Kapas, L., Shibata, M., and Krueger, J. M. (1995). Role of cytokines in sleep, fever and anorexia. In "Human Cytokines: Their Role in Disease and Therapy" (B. B. Aggarwal and R. K. Puri, Eds.), pp. 304-314. Blackwell Sci., Cambridge, MA.
34. Kärber, G. (1931). Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch. Exp. Pathol. Pharmakol. 152, 480-483.
35. Klupp, B. G., Lomniczi, B., Visser, N., Fuchs, W., and Mettenleiter, T. C. (1995). Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virology 212, 466-473.
36. Kritas, S. K., Pensaert, M. B., and Mettenleiter, T. C. (1994). Role of envelope glycoproteins gI, gp63 and gII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. J. Gen. Virol. 75, 2319-2327.
37. Limcumpao, J. A., Horimoto, T., Xuan, X., Tohya, Y., Azetaka, M., Takahashi, E., and Mikami, T. (1991). Homologous and heterologous antibody response s of mice immunized with purified feline herpesvirus type 1 and canine herpesvirus glycoproteins. J. Vet. Med. Sci. 53, 423-432.
38. Mestecky, J. (1987). The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7, 265-276.
39. Mettenleiter, T. C. (1991). Molecular biology of pseudorabies (Aujeszky's disease) virus. Comp. Immunol. Microbiol. Infect. Dis. 14, 151-163.
40. Mulder, W. A. M., Jacobs, L., Priem, J., Kok, G. L., Wagenaar, F., Kimman, T. G., and Pol, J. M. A. (1994). Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second and third order neurons of the olfactory and trigeminal routes in the porcine nervous system. J. Gen. Virol. 75, 3095-3106.
41. Nagura, H., Ohtani, H., Ando, N., Nakamura, S., and Kobayashi, K. (1994). The structural basis for the immune function of the digestive tract. In "Current Topics in Mucosal Immunology 1993" (M. Tsuchiya, Ed.), pp. 161-165. Elsevier, London.
42. Nasisse, M. P., English, R. V., Tompkins, M. B., Guy, J. S., and Sussman, W. (1995). Immunologic, histologic, and virologic features of herpesvirus-induced stromal keratitis in cats. Am. J. Vet. Res. 56, 51-55.
43. Norsworthy, G. (1995). Reflections on cats as pets and patients. Vet. Med. 90, 1036.
44. Nunberg, J., Wright, D. K., Cole, G. E., Petrovskis, E. A., Post, L. E., Compton, T., and Gilbert, J. H. (1989). Identification of the thymidine kinase gene of feline herpesvirus: Use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homolog. J. Virol. 63, 3240-3249.
45. Pedersen, N. C., and Hawkins, K. F. (1995). Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination. Vet. Microbiol. 47, 141-156.
46. Povey, R. C. (1979). A review of feline rhinotracheitis (feline herpesvirus 1 infection). Comp. Immunol. Microbiol. Infect. Dis. 2, 373-387.
47. Povey, R. C., and Wilson, M. R. (1978). A comparison of inactivated feline viral rhinotracheitis and feline caliciviral disease vaccines with live-modified viral vaccines. Feline Pract. 8, 35-42.
48. Rajcani, J. (1992). DNA regions and genes determining the virulence of herpes simplex virus. Acta Virol. 36, 208-222.
49. Roizman, B., and Sears, A. (1993). Herpes simplex viruses and their replication. In "The Human Herpesviruses" (B. Roizman, R. J. Whitely, and C. Lopez, Eds.), pp. 11 -68. Raven Press, New York.
50. Shields, R. P., and Gastin, J. M. (1977). Fatal generalized feline viral rhinotracheitis in a young adult cat. J. Am. Vet. Med. Assoc. 170, 439-441.
51. Spatz, S. J., Rota, P. A., and Maes, R. K. (1994). Identification of the feline herpesvirus type 1 genes encoding glycoproteins G, D, I and E: Expression of glycoprotein D (FHV-1) in vaccinia and raccoon poxviruses. J. Gen. Virol. 75, 1235-1244.
52. Spradbow, P. B., Carlisle, C., and Watt, D. A. (1971). The association of a herpesvirus with generalized disease in a kitten. Vet. Pec. 89, 542-544.
53. Sussman, M. D., Maes, R. K., Kruger, J. M., Spatz, S. J., and Venta, P. J. (1995). A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins, gI and gE is effective as a vaccine for feline rhinotracheitis. Virology 214, 12-20.
54. Tham, K. M., and Studdert, M. J. (1987). Antibody and cell-mediated immune responses to feline herpesvirus-1 following inactivated vaccine and challenge. J. Vet. Med. 34, 585-597.
55. Thompson, R. L., Wagner, E. K., and Stevens, J. G. (1983). Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology 131, 180-192.
56. U.S. Dept. of Agriculture, Animal and Plant Health Inspection Service, National Veterinary Services Laboratory (1985). "Supplemental Assay Method (311) for Scoring Feline Rhinotracheitis in Cats Following Virulent Virus Challenge." Ames, IA.
57. Van Engelenburg, F. A. C., Kaashoek, M. J., Rjsewijk, F. A. M., Van den Burg, L., Moerman, A., Gielkens, A. L. J., and Van Oirschot, J. T. (1994). A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol. 75, 2311-2318.
58. Wardley, R. C., Rouse, B. T., and Babiuk, L. A. (1976). Observations on recovery mechanisms from feline rhinotracheitis. Can. J. Comp. Med. 40, 257-264.
59. Willemse, M. J., Chalmers, W. S., Cronenberg, A. M., Pfundt, R., Strijdveen, I. G., and Sondermeijer, P. J. (1994). The gene downstream of the gC homologue in feline herpesvirus type 1 is involved in the expression of virulence. J. Gen. Virol. 75, 3107-3116.
60. Yao, Z, and Grose, C. (1994). Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J. Virol. 68, 4204-4211.
61. York, I. A., and Jahnson, D. C. (1993). Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell to cell spread of virus. J. Infect. Dis. 168, 1127-1132.
62. + T lymphocytes. Cell 77, 525-535.
63. Zhu, Z, Gershon, M. D., Hao, Y., Ambron, R. T., Gabel, C. A., and Gershon, A. A. (1995). Envelopment of varicella-zoster virus: Targeting of viral glycoproteins to the trans-Golgi network. J. Virol. 69, 7951-7959.
64. Zsak, L., Zuckerman, F., Sugg, N., and Ben-Porat, T. (1992). Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell to cell transmission. J. Virol. 66, 2316-2325.
65. Zuckerman, F. A., Mettenleiter, T. C., Schreurs, C., Sugg, N., and BenPorat, T. (1988). Complex between glycoproteins gI and gp63 of pseudorabies: Its effects on virus replication. J. Virol. 62, 4622-4626.